Safe administration of SARS-CoV-2 vaccine after desensitization to a biologic containing polysorbate 80 in a patient with polyethylene glycol-induced severe anaphylaxis and sensitization to polysorbate 80.

Nin-Valencia, A; Fiandor, A; Lluch, M; Quirce, S; Caballero, T; Heredia Revuelto, R; González-Muñoz, M; Caballero, M L; Cabañas, R

Nin-Valencia, A; Fiandor, A; Lluch, M; Quirce, S; Caballero, T; Heredia Revuelto, R; González-Muñoz, M; Caballero, M L; Cabañas, R.

Nin-Valencia A; Department of Allergy, Hospital Universitario La Paz, Madrid, Spain.
Fiandor A; Department of Allergy, Hospital Universitario La Paz, Madrid, Spain.
Lluch M; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Quirce S; PIELenRed Consortium.
Caballero T; Department of Allergy, Hospital Universitario La Paz, Madrid, Spain.
Heredia Revuelto R; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
González-Muñoz M; PIELenRed Consortium.
Caballero ML; Department of Allergy, Hospital Universitario La Paz, Madrid, Spain.
Cabañas R; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.

J Investig Allergol Clin Immunol ; : 0, 2022 May 31.

Article in English | MEDLINE | ID: covidwho-2300961

Keywords

Allergy; Desensitization; Infliximab; Polyethylene glycol; Polysorbates; SARS-CoV-2 vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: J Investig Allergol Clin Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: Jiaci.0830

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google